US Broker Ratings

BioLife Solutions, Inc. (BLFS) Stock Analysis: Strong Buy Ratings and a 31% Upside Potential

BioLife Solutions, Inc. (BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.13 billion, BioLife Solutions is a..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a Promising 22.85% Upside Potential

For investors eyeing opportunities in the biotechnology sector, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) presents an intriguing case. With a current market capitalization of $1.1 billion, this Canadian-based biopharmaceutical company is..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: 37.7% Potential Upside Beckons Investors

Establishment Labs Holdings Inc (NASDAQ: ESTA), a pioneering medical technology company in the healthcare sector, is making waves with its innovative solutions in the aesthetic and reconstructive plastic surgery industry...

Mesoblast Limited (MESO) Stock Analysis: A Biotech with 127.85% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an innovative player in the biotechnology sector, is capturing investor attention with a significant potential upside of 127.85%, according to recent analyst target prices. Headquartered in..

Biohaven Ltd. (BHVN) Investor Outlook: Potential 222.65% Upside Amid Promising Clinical Trials

Biohaven Ltd. (NYSE: BHVN) presents a compelling case for investors intrigued by the biotechnology sector, with its substantial potential upside of 222.65% based on current analyst ratings. This upside, coupled..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 25% Potential Upside in the Healthcare Sector

Investors looking for promising opportunities in the healthcare sector might find LeMaitre Vascular, Inc. (NASDAQ: LMAT) an intriguing option. This Burlington, Massachusetts-based company, a prominent player in the medical instruments..

CONMED Corporation (CNMD) Stock Analysis: Exploring an 11.22% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, offers an intriguing investment opportunity for those looking to capitalize on its robust market presence..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: 48.79% Potential Upside Fuels Investor Interest

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of dermatological treatments. Founded in 2016 and headquartered..

Aveanna Healthcare Holdings Inc (AVAH) Stock Report: Evaluating the 10.34% Potential Upside for Investors

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) stands as a unique player in the U.S. healthcare sector, specifically within the Medical Care Facilities industry. As a diversified home care platform, Aveanna..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Strategizing for a 117% Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents an intriguing opportunity for investors, especially given the substantial potential upside of 117.48% indicated by analyst targets. As a player in the biotechnology sector,..

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 89% Upside Potential in the Healthcare Sector

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is currently trading at $25.28, with investors keenly watching its potential for growth. With a market cap of..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 74.25% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices, has been drawing attention with its innovative solutions tailored for diabetes management. Headquartered..

Teladoc Health, Inc. (TDOC) Investor Outlook: A 21% Potential Upside Amidst Mixed Ratings

Teladoc Health, Inc. (TDOC), a pioneering entity in the health information services sector, provides a wide array of virtual healthcare services globally. As the healthcare industry increasingly embraces digital transformation,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Powerhouse with Nearly 200% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine. Based in Singapore, this clinical-stage company is dedicated to designing,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring the 50% Upside Potential in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector with its innovative approach to providing outpatient mental health services across the United States. Headquartered in Scottsdale,..

Indivior PLC (INDV) Stock Analysis: Exploring a 9.21% Potential Upside Amidst Strategic Developments

Indivior PLC (INDV) stands at a pivotal juncture in its journey within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic applications. With a market..

Viridian Therapeutics, Inc. (VRDN): Analyst Ratings Reveal 157% Upside Potential in Biotech Innovator

Viridian Therapeutics, Inc. (VRDN), a biotech company focused on developing novel treatments for rare and serious diseases, has captured the attention of investors with its promising product pipeline and substantial..

Harrow, Inc. (HROW) Investor Outlook: Analyst Ratings Shine Amid 81% Potential Upside

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector specializing in ophthalmic pharmaceuticals, is capturing investor attention with significant potential gains on the horizon. With an impressive market..

agilon health, inc. (AGL) Investor Outlook: Assessing Growth Potential Amid an 86% Upside

Agilon health, inc. (NYSE: AGL), a prominent player in the healthcare sector, specializes in providing comprehensive care solutions for seniors through primary care networks across the United States. Despite its..

Veracyte, Inc. (VCYT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 47%

Veracyte, Inc. (VCYT), a healthcare company specializing in diagnostics and research, has caught the attention of investors with its promising growth potential. Headquartered in South San Francisco, California, Veracyte operates..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds